1. Potent and selective CC chemokine receptor 1 antagonists labeled with carbon-13, carbon-14, and tritium
- Author
-
Maxim Cheveliakov, Matt Hrapchak, Carl A. Busacca, Jonathan T. Reeves, Bachir Latli, Chris H. Senanayake, and Maurice A. Marsini
- Subjects
0301 basic medicine ,CCR1 ,Chemistry ,Organic Chemistry ,Radiosynthesis ,Radiochemistry ,Carbon-13 ,01 natural sciences ,Biochemistry ,0104 chemical sciences ,Analytical Chemistry ,010404 medicinal & biomolecular chemistry ,03 medical and health sciences ,030104 developmental biology ,Drug Discovery ,Radiology, Nuclear Medicine and imaging ,Tritium ,Carbon-14 ,CC chemokine receptors ,Spectroscopy - Abstract
1-(4-Fluorophenyl)-1H-pyrazolo[3,4-c]pyridine-4-carboxylic acid (2-methanesulfonyl-pyridin-4-ylmethyl)-amide (1) and its analogs (2) and (3) are potent CCR1 antagonists intended for the treatment of rheumatoid arthritis. The detailed syntheses of these 3 compounds labeled with carbon-13 as well as the preparation of (1) and (2) labeled with carbon-14, and (1) labeled with tritium, are described.
- Published
- 2018
- Full Text
- View/download PDF